메뉴 건너뛰기




Volumn 13, Issue 12, 2011, Pages 917-924

Carvedilol Reduces Aortic Wave Reflection and Improves Left Ventricular/Vascular Coupling: A Comparison With Atenolol (CENTRAL Study)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; CARVEDILOL;

EID: 83055180598     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2011.00549.x     Document Type: Article
Times cited : (35)

References (42)
  • 1
    • 0038460302 scopus 로고    scopus 로고
    • The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report
    • Bakris GL, Black HR
    • Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
    • (2003) JAMA , vol.289 , pp. 2560-2572
    • Chobanian, A.V.1
  • 2
    • 34548383480 scopus 로고    scopus 로고
    • ESH-ESC task force on the management of arterial hypertension. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension
    • Mancia G, De Backer G, Dominiczak A, et al. ESH-ESC task force on the management of arterial hypertension. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens. 2007;25:1751-1762.
    • (2007) J Hypertens , vol.25 , pp. 1751-1762
    • Mancia, G.1    De Backer, G.2    Dominiczak, A.3
  • 4
    • 33645518432 scopus 로고    scopus 로고
    • Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the conduit artery function evaluation (CAFE) study
    • Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the conduit artery function evaluation (CAFE) study. Circulation. 2006;113:1213-1225.
    • (2006) Circulation , vol.113 , pp. 1213-1225
    • Williams, B.1    Lacy, P.S.2    Thom, S.M.3
  • 5
    • 7644236592 scopus 로고    scopus 로고
    • Atenolol in hypertension: is it a wise choice?
    • Carlberg B, Samuelsson O, Lindholm LH. Atenolol in hypertension: is it a wise choice? Lancet. 2004;364:1684-1689.
    • (2004) Lancet , vol.364 , pp. 1684-1689
    • Carlberg, B.1    Samuelsson, O.2    Lindholm, L.H.3
  • 6
    • 27544463207 scopus 로고    scopus 로고
    • Should b-blockers remain first choice in the treatment of primary hypertension? A meta-analysis
    • Lindholm LH, Carlberg B, Samuelsson O. Should b-blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet. 2005;366:1545-1553.
    • (2005) Lancet , vol.366 , pp. 1545-1553
    • Lindholm, L.H.1    Carlberg, B.2    Samuelsson, O.3
  • 7
    • 0037160968 scopus 로고    scopus 로고
    • Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
    • Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359:995-1003.
    • (2002) Lancet , vol.359 , pp. 995-1003
    • Dahlof, B.1    Devereux, R.B.2    Kjeldsen, S.E.3
  • 8
    • 77954685772 scopus 로고    scopus 로고
    • Antihypertensive treatment with beta-blockers in the metabolic syndrome: a review
    • Carella AM, Antonucci G, Conte M, et al. Antihypertensive treatment with beta-blockers in the metabolic syndrome: a review. Curr Diabetes Rev. 2010;6:215-221.
    • (2010) Curr Diabetes Rev , vol.6 , pp. 215-221
    • Carella, A.M.1    Antonucci, G.2    Conte, M.3
  • 9
    • 0038312287 scopus 로고    scopus 로고
    • Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis
    • Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA. 2003;289:2534-2544.
    • (2003) JAMA , vol.289 , pp. 2534-2544
    • Psaty, B.M.1    Lumley, T.2    Furberg, C.D.3
  • 10
    • 0032540714 scopus 로고    scopus 로고
    • Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review
    • Messerli FH, Grossman F, Goldbourt U. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. J Am Med Assoc. 1998;279:1903-1907.
    • (1998) J Am Med Assoc , vol.279 , pp. 1903-1907
    • Messerli, F.H.1    Grossman, F.2    Goldbourt, U.3
  • 11
    • 33744970717 scopus 로고    scopus 로고
    • Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis
    • Khan N, McAlister FA. Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. CMAJ. 2006;174:1737-1742.
    • (2006) CMAJ , vol.174 , pp. 1737-1742
    • Khan, N.1    McAlister, F.A.2
  • 12
    • 77149162035 scopus 로고    scopus 로고
    • Wave reflection and arterial stiffness in the prediction of 15-year all cause and cardiovascular mortalities: a community-based study
    • Wang KL, Cheng HM, Sung Sh, et al. Wave reflection and arterial stiffness in the prediction of 15-year all cause and cardiovascular mortalities: a community-based study. Hypertension. 2010;55:799-805.
    • (2010) Hypertension. , vol.55 , pp. 799-805
    • Wang, K.L.1    Cheng, H.M.2    Sung, S.3
  • 13
    • 77954814318 scopus 로고    scopus 로고
    • Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis
    • Vlachopoulos C, Aznaouridis K, O'Rourke MF, et al. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J. 2010;31:1865-1871.
    • (2010) Eur Heart J , vol.31 , pp. 1865-1871
    • Vlachopoulos, C.1    Aznaouridis, K.2    O'Rourke, M.F.3
  • 14
    • 77957236665 scopus 로고    scopus 로고
    • The impact of cardiovascular risk factors on aortic stiffness and wave reflections depends on age: the Anglo-Cardiff Collaborative Trial (ACCT III)
    • McEniery CM, Yasmin, Maki-Petaja KM, et al. The impact of cardiovascular risk factors on aortic stiffness and wave reflections depends on age: the Anglo-Cardiff Collaborative Trial (ACCT III). Hypertension. 2010;56:591-597.
    • (2010) Hypertension. , vol.56 , pp. 591-597
    • Mceniery, C.M.1    Yasmin2    Maki-Petaja, K.M.3
  • 15
    • 0012666855 scopus 로고    scopus 로고
    • Aortic stiffness is an independent predictor of fatal stroke in essential hypertension
    • Laurent S, Katsahian S, Fassot C, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003;34:1203-1206.
    • (2003) Stroke , vol.34 , pp. 1203-1206
    • Laurent, S.1    Katsahian, S.2    Fassot, C.3
  • 16
    • 33750318148 scopus 로고    scopus 로고
    • Expert consensus document on arterial stiffness: methodological issues and clinical applications
    • Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588-2605.
    • (2006) Eur Heart J , vol.27 , pp. 2588-2605
    • Laurent, S.1    Cockcroft, J.2    Van Bortel, L.3
  • 17
    • 7744237066 scopus 로고    scopus 로고
    • Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial
    • Bakris GL, Fonseca V, Katholi RE, et al. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA. 2004;292:2227-2236.
    • (2004) JAMA , vol.292 , pp. 2227-2236
    • Bakris, G.L.1    Fonseca, V.2    Katholi, R.E.3
  • 18
    • 33747835974 scopus 로고    scopus 로고
    • Metabolic effects of beta-adrenoceptor antagonists with special emphasis on carvedilol
    • Kveiborg B, Christiansen B, Major-Petersen A, et al. Metabolic effects of beta-adrenoceptor antagonists with special emphasis on carvedilol. Am J Cardiovasc Drugs. 2006;6:209-217.
    • (2006) Am J Cardiovasc Drugs. , vol.6 , pp. 209-217
    • Kveiborg, B.1    Christiansen, B.2    Major-Petersen, A.3
  • 19
    • 24644443331 scopus 로고    scopus 로고
    • Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian cardiac outcomes trial-blood pressure lowering arm (ASCOT-BPLA): a multicentre randomized controlled trial
    • Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian cardiac outcomes trial-blood pressure lowering arm (ASCOT-BPLA): a multicentre randomized controlled trial. Lancet. 2005;366:895-906.
    • (2005) Lancet , vol.366 , pp. 895-906
    • Dahlof, B.1    Sever, P.S.2    Poulter, N.R.3
  • 20
    • 44349118138 scopus 로고    scopus 로고
    • β-Blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection
    • Mahmud A, Feely J. β-Blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection. Am J Hyperten. 2008;21:663-667.
    • (2008) Am J Hyperten , vol.21 , pp. 663-667
    • Mahmud, A.1    Feely, J.2
  • 21
    • 0035726587 scopus 로고    scopus 로고
    • Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patients: a comparison with atenolol
    • Asmar RG, London GM, O'Rourke M, et al. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patients: a comparison with atenolol. Hypertension. 2001;38:922-926.
    • (2001) Hypertension. , vol.38 , pp. 922-926
    • Asmar, R.G.1    London, G.M.2    O'Rourke, M.3
  • 22
    • 0034657775 scopus 로고    scopus 로고
    • The influence of heart rate on augmentation index and central arterial pressure in humans
    • Wilkinson IB, MacCallum H, Flint L, et al. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol. 2000;525:263-270.
    • (2000) J Physiol , vol.525 , pp. 263-270
    • Wilkinson, I.B.1    MacCallum, H.2    Flint, L.3
  • 23
    • 0022826404 scopus 로고
    • Arterial hemodynamics in human hypertension
    • Ting CT, Brin KP, Lin SJ, et al. Arterial hemodynamics in human hypertension. J Clin Invest. 1986;78:1462-1471.
    • (1986) J Clin Invest , vol.78 , pp. 1462-1471
    • Ting, C.T.1    Brin, K.P.2    Lin, S.J.3
  • 24
    • 77649166914 scopus 로고    scopus 로고
    • Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy
    • Xiaozhen H, Yun Z, Mei Z, et al. Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy. Blood Press. 2010;19:40-47.
    • (2010) Blood Press , vol.19 , pp. 40-47
    • Xiaozhen, H.1    Yun, Z.2    Mei, Z.3
  • 25
    • 0024336442 scopus 로고
    • Arterial dilatation and reduced wave reflection: benefit of dilevalol in hypertension
    • Kelly RP, Daley J, Avolio A, et al. Arterial dilatation and reduced wave reflection: benefit of dilevalol in hypertension. Hypertension. 1989;14:14-21.
    • (1989) Hypertension , vol.14 , pp. 14-21
    • Kelly, R.P.1    Daley, J.2    Avolio, A.3
  • 26
    • 0035979349 scopus 로고    scopus 로고
    • Nobivolol reverses endothelial dysfunction in essential hypertension: a randomised, double blind, crossover study
    • Tzemos N, Lim PO, MacDonald TM. Nobivolol reverses endothelial dysfunction in essential hypertension: a randomised, double blind, crossover study. Circulation. 2001;104:511-514.
    • (2001) Circulation , vol.104 , pp. 511-514
    • Tzemos, N.1    Lim, P.O.2    MacDonald, T.M.3
  • 27
    • 33750284959 scopus 로고    scopus 로고
    • Different effects of atenolol and nebivolol on coronary flow reserve
    • Gullu H, Erdogan D, Caliskan M, et al. Different effects of atenolol and nebivolol on coronary flow reserve. Heart. 2006;92:1690-1691.
    • (2006) Heart , vol.92 , pp. 1690-1691
    • Gullu, H.1    Erdogan, D.2    Caliskan, M.3
  • 28
    • 77957560278 scopus 로고    scopus 로고
    • Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers
    • Polónia J, Barbosa L, Silva JA, et al. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers. Blood Press Monit. 2010;15:235-239.
    • (2010) Blood Press Monit. , vol.15 , pp. 235-239
    • Polónia, J.1    Barbosa, L.2    Silva, J.A.3
  • 29
    • 34250862170 scopus 로고    scopus 로고
    • Central blood pressure measurements and antihypertensive therapy: a consensus document
    • Agabiti-Rosei E, Mancia G, O'Rourke MF, et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension. 2007;50:154-160.
    • (2007) Hypertension , vol.50 , pp. 154-160
    • Agabiti-Rosei, E.1    Mancia, G.2    O'Rourke, M.F.3
  • 30
    • 68549104289 scopus 로고    scopus 로고
    • Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data
    • Avolio AP, Van Bortel LM, Boutouyrie P, et al. Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data. Hypertension. 2009;54:375-383.
    • (2009) Hypertension. , vol.54 , pp. 375-383
    • Avolio, A.P.1    Van Bortel, L.M.2    Boutouyrie, P.3
  • 32
    • 33947111435 scopus 로고    scopus 로고
    • Antioxidant activity of carvedilol in cardiovascular disease
    • Dandona P, Ghanim H, Brooks DP. Antioxidant activity of carvedilol in cardiovascular disease. J Hypertens. 2007;25:731-741.
    • (2007) J Hypertens , vol.25 , pp. 731-741
    • Dandona, P.1    Ghanim, H.2    Brooks, D.P.3
  • 33
    • 33846579639 scopus 로고    scopus 로고
    • The antioxidative effects of long-term treatment are more pronounced for carvedilol than for atenolol in post-myocardial infarction patients
    • Jonsson G, Abdelnoor M, Seljeflot I, et al. The antioxidative effects of long-term treatment are more pronounced for carvedilol than for atenolol in post-myocardial infarction patients. J CardiovascPharmacol. 2007;49:27-32.
    • (2007) J CardiovascPharmacol. , vol.49 , pp. 27-32
    • Jonsson, G.1    Abdelnoor, M.2    Seljeflot, I.3
  • 34
    • 34248529784 scopus 로고    scopus 로고
    • The early anti-oxidant effect of carvedilol predicts the clinical course in congestive heart failure patients
    • Goldhammer E, Maor I, Shnitzer S, et al. The early anti-oxidant effect of carvedilol predicts the clinical course in congestive heart failure patients. J Cardiovasc Med (Hagerstown). 2007;8:453-456.
    • (2007) J Cardiovasc Med (Hagerstown) , vol.8 , pp. 453-456
    • Goldhammer, E.1    Maor, I.2    Shnitzer, S.3
  • 35
    • 33645373309 scopus 로고    scopus 로고
    • Carvedilol action is dependent on endogenous production of nitric oxide
    • Afonso RA, Patarrao RS, Macedo MP, et al. Carvedilol action is dependent on endogenous production of nitric oxide. Am J Hypertens. 2006;19:419-425.
    • (2006) Am J Hypertens , vol.19 , pp. 419-425
    • Afonso, R.A.1    Patarrao, R.S.2    Macedo, M.P.3
  • 36
    • 33749126575 scopus 로고    scopus 로고
    • Controlled-release carvedilol in the treatment of essential hypertension
    • Weber MA, Sica DA, Tarka EA, et al. Controlled-release carvedilol in the treatment of essential hypertension. Am J Cardiol. 2006;98(suppl 7):32L-38L.
    • (2006) Am J Cardiol , vol.98 , Issue.SUPPL. 7
    • Weber, M.A.1    Sica, D.A.2    Tarka, E.A.3
  • 37
    • 83055168001 scopus 로고    scopus 로고
    • Zeneca Pharmaceuticals. Tenormin [package insert]. Wilmington, DE: Zeneca Pharmaceuticals
    • Zeneca Pharmaceuticals. Tenormin [package insert]. Wilmington, DE: Zeneca Pharmaceuticals; 1997.
    • (1997)
  • 38
    • 83055191758 scopus 로고    scopus 로고
    • GlaxoSmithKline. Coreg CR [package insert]. Research Triangle Park, NC; GlaxoSmithKline; October
    • GlaxoSmithKline. Coreg CR [package insert]. Research Triangle Park, NC; GlaxoSmithKline; October 2006.
    • (2006)
  • 39
    • 79956343749 scopus 로고    scopus 로고
    • Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness
    • Kampus P, Serg M, Kals J, et al. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness. Hypertension. 2011; 57(6):1122-1128.
    • (2011) Hypertension , vol.57 , Issue.6 , pp. 1122-1128
    • Kampus, P.1    Serg, M.2    Kals, J.3
  • 40
    • 0034027085 scopus 로고    scopus 로고
    • Prepubertal stature and blood pressure in early old age
    • Montgomery SM, Berney LR, Blane D. Prepubertal stature and blood pressure in early old age. Arch Dis Child. 2000;82:358-363.
    • (2000) Arch Dis Child , vol.82 , pp. 358-363
    • Montgomery, S.M.1    Berney, L.R.2    Blane, D.3
  • 41
    • 0037360617 scopus 로고    scopus 로고
    • Influence of height, leg and trunk length on pulse pressure, systolic and diastolic blood pressure
    • Langenberg C, Hardy R, Kuh D, et al. Influence of height, leg and trunk length on pulse pressure, systolic and diastolic blood pressure. J Hypertens. 2003;21:537-543.
    • (2003) J Hypertens , vol.21 , pp. 537-543
    • Langenberg, C.1    Hardy, R.2    Kuh, D.3
  • 42
    • 0032054270 scopus 로고    scopus 로고
    • Influence of body height on pulsatile arterial hemodynamic data
    • Smulyan H, Marchais SJ, Pannier B, et al. Influence of body height on pulsatile arterial hemodynamic data. J Am CollCardiol. 1998;31:1103-1109.
    • (1998) J Am CollCardiol , vol.31 , pp. 1103-1109
    • Smulyan, H.1    Marchais, S.J.2    Pannier, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.